1-2 of 2
Georgios Gkortzolidis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Prognostic Impact of Other Somatic Mutations and Cytogenetic Abnormalities in Patients with NPM1 and/or FLT3-ITD Mutated AML in the Era of FLT3-Inhibitors: Real-Life Data from the Greek AML Registry

Ioanna Lazana, Panagiotis Tsirigotis, Ioannis Konstantellos, Spiros Chondropoulos, Maria Stamouli, Konstantinos Gkirkas, Ioannis Baltadakis, Evrydiki Theodorou, Frini Karaolidou, Tatiana Tzenou, Ioanna Sakellari, Maria Papathanasiou, Chrysavgi Lalayanni, Apostolia Papalexandri, Vasiliki Violaki, Eleftheria Hatzimichael, Lydia Kyriazopoulou, Eleni Kapsali, Dora Gougopoulou, Amalia Vassou, Sofia Charalampidou, Maria Angelopoulou, Eleni Plata, Maria Papaioannou, Ioannis Vasileios Asimakopoulos, Anastasia Kopsaftopoulou, Theodoros Vassilakopoulos, Demitris Kousiafes, Theoni Leonidopoulou, Georgia Gkolfinopoulou, Panagiota Katsiampoura, Chrysanthi Vadikoliou, Theodoros Marinakis, Georgios Gkortzolidis, Eyrydiki Michalis, Maria Vardaka
Journal: Blood
Blood (2024) 144 (Supplement 1): 5956.
https://doi.org/10.1182/blood-2024-208119
Published: 2024
Journal Articles

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

Clinical Trials & Observations
Efstathios Kastritis, Evangelos Terpos, Maria Roussou, Maria Gavriatopoulou, Constantinos Pamboukas, Ioannis Boletis, Smaragda Marinaki, Theofanis Apostolou, Nikitas Nikitas, Georgios Gkortzolidis, Eurydiki Michalis, Sossana Delimpasi, Meletios A. Dimopoulos
Journal: Blood
Blood (2012) 119 (23): 5384–5390.
https://doi.org/10.1182/blood-2011-12-396903
Published: 2012
Includes: Supplemental data